Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Pancreatic Cancer × fluzoparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 1 SCLC, Extensive Stage 1 Advanced Solid Tumors 1 Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 2 toripalimab 1 penpulimab 1 fluzoparib 1 conteltinib 1 Paclitaxel 1 Nivolumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04228601 2024-08-16

A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1/2 Completed

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡